394 related articles for article (PubMed ID: 21128240)
21. Radial scars diagnosed on breast core biopsy: Frequency of atypia and carcinoma on excision and implications for management.
Donaldson AR; Sieck L; Booth CN; Calhoun BC
Breast; 2016 Dec; 30():201-207. PubMed ID: 27371970
[TBL] [Abstract][Full Text] [Related]
22. Radial scars/complex sclerosing lesions and malignancy in a screening programme: incidence and histological features revisited.
Doyle EM; Banville N; Quinn CM; Flanagan F; O'Doherty A; Hill AD; Kerin MJ; Fitzpatrick P; Kennedy M
Histopathology; 2007 Apr; 50(5):607-14. PubMed ID: 17394497
[TBL] [Abstract][Full Text] [Related]
23. Lesions of uncertain malignant potential of the breast (B3) on vacuum-assisted biopsy for microcalcifications: Predictors of malignancy.
Mariscotti G; Durando M; Ruggirello I; Belli P; Caumo F; Nori J; Zuiani C; Tagliafico A; Bicchierai G; Romanucci G; Londero V; Campanino PP; Bussone R; Castellano I; Mule' A; Caneva A; Bianchi S; Di Loreto C; Bergamasco L; Calabrese M; Fonio P; Houssami N
Eur J Radiol; 2020 Sep; 130():109194. PubMed ID: 32795765
[TBL] [Abstract][Full Text] [Related]
24. Large volume "mammotome" biopsy may reduce the need for diagnostic surgery in papillary lesions of the breast.
Carder PJ; Khan T; Burrows P; Sharma N
J Clin Pathol; 2008 Aug; 61(8):928-33. PubMed ID: 18495791
[TBL] [Abstract][Full Text] [Related]
25. An audit of mammographic screen detected lesions of uncertain malignant potential (B3) diagnosed on initial image guided needle biopsy: how has our practice changed over 10 years?
Batohi B; Fang C; Michell MJ; Morel J; Shah C; Wijesuriya S; Peacock C; Rahim R; Wasan R; Goligher J; Satchithananda K
Clin Radiol; 2019 Aug; 74(8):653.e19-653.e25. PubMed ID: 31078275
[TBL] [Abstract][Full Text] [Related]
26. Uncommon high-risk lesions of the breast diagnosed at stereotactic core-needle biopsy: clinical importance.
Philpotts LE; Shaheen NA; Jain KS; Carter D; Lee CH
Radiology; 2000 Sep; 216(3):831-7. PubMed ID: 10966718
[TBL] [Abstract][Full Text] [Related]
27. Will the spectrum of lesions prompting a "B3" breast core biopsy increase the benign biopsy rate?
Carder PJ; Liston JC
J Clin Pathol; 2003 Feb; 56(2):133-8. PubMed ID: 12560393
[TBL] [Abstract][Full Text] [Related]
28. Imaging-guided core needle biopsy of papillary lesions of the breast.
Rosen EL; Bentley RC; Baker JA; Soo MS
AJR Am J Roentgenol; 2002 Nov; 179(5):1185-92. PubMed ID: 12388496
[TBL] [Abstract][Full Text] [Related]
29. Positive predictive value for malignancy of pure flat epithelial atypia diagnosis by percutaneous needle biopsy of the breast: management of FEA in ultrasonography.
Maeda I; Kanemaki Y; Tozaki M; Koizumi H; Oana Y; Okanami Y; Tsuchiya K; Shimo A; Kojima Y; Hayami R; Nishikawa T; Kawamoto H; Yabuki Y; Tsugawa K; Takagi M
Breast Cancer; 2015 Nov; 22(6):634-40. PubMed ID: 24760612
[TBL] [Abstract][Full Text] [Related]
30. Our Radiological Experience on B3 Lesions: Correlation Between Mammographic and MRI Findings With Histologic Definitive Result.
Santucci D; Faiella E; Calabrese A; Favale L; Zobel BB; de Felice C
Clin Breast Cancer; 2019 Oct; 19(5):e643-e653. PubMed ID: 31377083
[TBL] [Abstract][Full Text] [Related]
31. B3 lesion upgrade rates in a tertiary Australian breast centre: a 8-year experience (2012-2019).
Huang YY; Park H; McLaren S; Thirunavukkarasu P; Lin JTW; Rajakaruna R; Dhillon R; Ponniah AK
ANZ J Surg; 2020 Dec; 90(12):2521-2526. PubMed ID: 32969161
[TBL] [Abstract][Full Text] [Related]
32. The positive predictive value of vacuum assisted biopsy (VAB) in predicting final histological diagnosis for breast lesions of uncertain malignancy (B3 lesions): A systematic review & meta-analysis.
Cullinane C; Byrne J; Kelly L; O Sullivan M; Antony Corrigan M; Paul Redmond H
Eur J Surg Oncol; 2022 Jul; 48(7):1464-1474. PubMed ID: 35491362
[TBL] [Abstract][Full Text] [Related]
33. Surgical excision for B3 breast lesions diagnosed by vacuum-assisted core biopsy.
Reefy S; Osman H; Chao C; Perry N; Mokbel K
Anticancer Res; 2010 Jun; 30(6):2287-90. PubMed ID: 20651381
[TBL] [Abstract][Full Text] [Related]
34. B3 Breast Lesions: Positive Predictive Value and Follow-Up on a Large Single-Institution Series.
Bernini M; Spolveri F; Tofani L; De Benedetto D; Bicchierai G; Bellini C; Morrone D; Nori Cucchiari J; Bianchi S; Livi L; Orzalesi L; Meattini I
J Surg Res; 2024 Jul; 299():366-373. PubMed ID: 38815523
[TBL] [Abstract][Full Text] [Related]
35. Pathologic review of atypical hyperplasia identified by image-guided breast needle core biopsy. Correlation with excision specimen.
Yeh IT; Dimitrov D; Otto P; Miller AR; Kahlenberg MS; Cruz A
Arch Pathol Lab Med; 2003 Jan; 127(1):49-54. PubMed ID: 12521366
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis and management of benign, atypical, and indeterminate breast lesions detected on core needle biopsy.
Neal L; Sandhu NP; Hieken TJ; Glazebrook KN; Mac Bride MB; Dilaveri CA; Wahner-Roedler DL; Ghosh K; Visscher DW
Mayo Clin Proc; 2014 Apr; 89(4):536-47. PubMed ID: 24684875
[TBL] [Abstract][Full Text] [Related]
37. The outcome of papillary lesions of the breast diagnosed by standard core needle biopsy within a BreastScreen Australia service.
Armes JE; Galbraith C; Gray J; Taylor K
Pathology; 2017 Apr; 49(3):267-270. PubMed ID: 28238415
[TBL] [Abstract][Full Text] [Related]
38. Predictors of invasive breast cancer in mammographically detected microcalcification in patients with a core biopsy diagnosis of flat epithelial atypia, atypical ductal hyperplasia or ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy.
Catteau X; Simon P; Noël JC
Pathol Res Pract; 2012 Apr; 208(4):217-20. PubMed ID: 22445178
[TBL] [Abstract][Full Text] [Related]
39. Significance of flat epithelial atypia on mammotome core needle biopsy: Should it be excised?
Kunju LP; Kleer CG
Hum Pathol; 2007 Jan; 38(1):35-41. PubMed ID: 17095049
[TBL] [Abstract][Full Text] [Related]
40. Three-year Trends in Diagnosis of B3 Breast Lesions and Their Upgrade Rates to Malignant Lesions.
Griffiths R; Kaur C; Alarcon L; Szollosi Z
Clin Breast Cancer; 2020 Jun; 20(3):e353-e357. PubMed ID: 32171702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
